China focus: Latest developments in China’s booming beauty market

China on map of Asia

We round up recent developments in the Chinese beauty market, including new skin care lines by Florasis and Good Pharma Dermatology, APR Corp’s sales performance, Sa Sa’s challenges, and more.

‘Beauty and wellbeing are tied together’: Florasis to launch skin care line in 2025 as interest in TCM, well-being surges

C-beauty major Florasis will launch a skin care line next year, tapping into the resurgence of interest in traditional Chinese medicine (TCM) in beauty as consumers prioritise health and well-being.

The skin care line will build on the brand’s use of natural TCM ingredients in its formulations.

Speaking to CosmeticsDesign-Asia, Gabby Chen, global expansion president of Florasis, highlighted the many traditional ingredients the brand uses in its colour cosmetic products, including lotus seed oil, peony seed oil, pearl powder, and jade powder.

She noted that consumers were increasingly mindful of what they consume or apply, and traditional ingredients offer time-tested solutions.

APR Corp thriving in Japan and Chinese-speaking markets, to expand overseas sales channels for new products

South Korean beauty tech firm APR Corp aims to build on its promising sales performances in Japan and China, while broadening overseas sales channels for new products.

Since the company debuted medicube AGE-R Derma EMS Shot in March 2021, the cumulative global sales of this beauty device range have exceeded 2.5m units as of September 2024.

APR has attributed the results to two factors, namely “solid performance” in the domestic market and rapid growth in overseas markets.

Vytle for all: Suu Balm makers aim to broaden consumer base with new menthol-less brand

Good Pharma Dermatology, the company behind sensitive skin care brand Suu Balm, is seeking to attract a broader consumer base seeking effective, dermatologist-backed skin care through a new launch called Vytle.

Vytle released two products – a lotion and a cleanser – in end September. Not only are the products dermatologist-formulated at Singapore’s National Skin Centre (NSC), but they have also been certified hypoallergenic.

The brand claims that when used together, the products can double skin’s moisture upon first use. These results were based on a clinical study conducted on 15 subjects for a period of one week.

‘Challenged by headwinds’: Sa Sa operations hit by low consumption, rising outbound travel trends

Beauty retailer Sa Sa’s latest quarterly highlights major challenges, such as reduced local consumption and increased outbound travel, in key markets Hong Kong and Macau.

Hong Kong-headquartered Sa Sa International Holdings Limited reported that for the quarter ending September 30, the Group’s turnover was HKD975.9m (USD125.6m), a decline of 11% year over year.

According to a press statement, the group said its operations “have been challenged by headwinds” that have persisted since the first quarter.

Iron metabolism linked to psoriasis, zinc and selenium intake may reduce atopic dermatitis risk – study

A recent study by Chinese researchers has found that iron metabolism is linked to the onset of psoriasis, and that the intake of zinc and selenium could lower the risk of atopic dermatitis (AD).

Total iron-binding capacity (TIBC) and transferrin saturation (TSAT) are critical biomarkers for evaluating iron metabolism and storage in the body. Abnormally high and low TSAT levels signal a disruption in iron homeostasis.

The analysis showed a significant association between TSAT and psoriasis (p = 0.004), whereby each unit increase in TSAT level was linked to an average 18% rise in psoriasis risk.

In addition, elevated serum levels of zinc and selenium were found to effectively reduce the risk of AD (p = 0.039).